Bio-Connect
WB analysis of human plasminogen protein using GTX26189 Plasminogen antibody. Lane 1 : Reduced Plasminogen (R) Lane 2 : Non-reduced Plasminogen (NR) Loading : 1 microg Dilution : 1:3000
WB analysis of human plasminogen protein using GTX26189 Plasminogen antibody. Lane 1 : Reduced Plasminogen (R) Lane 2 : Non-reduced Plasminogen (NR) Loading : 1 microg Dilution : 1:3000
WB analysis of human plasminogen protein using GTX26189 Plasminogen antibody. Lane 1 : Reduced Plasminogen (R) Lane 2 : Non-reduced Plasminogen (NR) Loading : 1 microg Dilution : 1:3000

Plasminogen antibody

GTX26189
GeneTex
ApplicationsWestern Blot, ELISA
Product group Antibodies
ReactivityHuman
TargetPLG
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Plasminogen antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:2000-1:10000. ELISA: 1:20000-1:100000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ELISA
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    10 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID5340
  • Target name
    PLG
  • Target description
    plasminogen
  • Target synonyms
    HAE4; plasmin; plasminogen
  • Host
    Goat
  • Isotype
    IgG
  • Protein IDP00747
  • Protein Name
    Plasminogen
  • Scientific Description
    Plasminogen is a plasma protein synthesised mostly in the liver. Plasma concentration is usually in the range of 70 - 200mg/L. Plasminogen is activated by tissue-plasminogen activator, urokinase and streptokinase, to form plasmin. Activation results from the cleavage and release of the preactivation peptide. Angiostatin, an internal fragment of plasminogen, is a potent inhibitor of angiogenesis, which selectively inhibits endothelial cell proliferation. Angiostatin potently inhibits tumor growth and can maintain metastatic and primary tumors in a dormant state. It is defined by a balance of proliferation and apoptosis of the tumor cells and is composed of plasminogen first four cringle structures. This molecule is generated by proteolytic cleavage of plasminogen.
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203